Silver Book Fact

Subthalamic nuclei deep brain stimulation (STN-DBS) raises pain thresholds in Parkinson’s disease patients.

Dellapina E, Ory- Magne F, Regragui W, Thalamas C, et al. Effect of Subthalamic Deep Brain Stimulation in Parkinson’s Disease. Pain. 2012; 153(11): 2267-73. https://journals.lww.com/pain/Abstract/2012/11000/Effect_of_subthalamic_deep_brain_stimulation_on.18.aspx

Reference

Title
Effect of Subthalamic Deep Brain Stimulation in Parkinson’s Disease
Publication
Pain
Publication Date
2012
Authors
Dellapina E, Ory- Magne F, Regragui W, Thalamas C, et al.
Volume & Issue
Volume 153, Issue 11
Pages
2267-73
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • A proteasome inhibitor was found to reduce pain and joint destruction in an animal model of osteoarthritis, suggesting that nontoxic proteasome inhibitors could offer a novel pharmacotherapy option.  
  • People with persistent pain who used complementary and alternative medicine (CAM) had lower average health care expenditures than nonusers ($3,797 versus $4,153).  
  • Subthalamic nuclei deep brain stimulation (STN-DBS) raises pain thresholds in Parkinson’s disease patients.  
  • Pain education programs and pain consultations have been found to improve pain (average pain was 31% versus 20%) and daily interference (20% versus 2.5%) in oncology outpatients. Patient adherence…  
  • Resolvins, a family of lipid mediators, have shown potential in resolving persistent inflammatory pain.